Pharmacy-based Testing and Treatment for Gonorrhea and Chlamydia

基于药物的淋病和衣原体检测和治疗

• 批准号: 489129
• 负责人: Wilby Kyle J
• 金额: $ 6.75万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-05-01 至 2024-05-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489129&lang=en
• 关键词: Chlamydia; Gonorrhea; Pharmacy; Sexually Transmitted Infections

Gonorrhea and chlamydia are major public health concerns with increasing rates of infection occurring across Canada. Access to testing and treatment reduced during the COVID-19 pandemic, which puts communities at risk of increased transmission. This is a

淋病和衣原体是主要的公共卫生问题，在加拿大各地的感染率不断上升。在COVID-19大流行期间，检测和治疗的机会减少，使社区面临传播增加的风险。这是一